Goldenrod Therapeutics: SeedDevelops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathwaysOct 4, 2026RoundOSGoldenrod TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeed